Supply Chain

Supply Chain

Biodefense Headlines – 27 April 2025

News Scan April 27, 2025

This week’s topics include a consensus on the Pandemic Treaty, a Marburg vaccine Phase II trial, legislation to increase stockpile readiness for anthrax bioterrorism, and the EU updating its medical…

The Next Pandemic Won’t Wait: Strengthening the UK’s Medical Supply Chains Now

DARPA Announces EQUIP-A-Pharma Program to Advance Agile Pharmaceutical Manufacturing

Maxim Biomedical Secures $49.5M Manufacturing Award from HHS to Strengthen Pandemic Testing Efforts

Ontario Supporting $165M Investment to Secure Critical PPE Supply

HHS Awards $600M to 12 Manufacturers to Bolster COVID-19 Test Supply Chain

The Need for Speed in Biodefense: How JPEO-CBRND is Positioning for Rapid Response

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

On Demand Pharmaceuticals Opens State-of-the-Art Manufacturing Facility in Maryland

U.S. Delivers Additional Vaccines and Freezer Trucks to Bangladesh for COVID Vaccination Efforts

The US National Blood Crisis: Supply at 10-year Low From Pandemic Disruptions

Enhanced Drug Distribution Security at the Package Level

Scientists Show Plasma Technology Can Safely Clean Disposable PPE for Reuse

Dial-a-Threat Rapid Assay Generation Program Could Bypass Reliance on Cold-Chain Supply

New Manufacturing Plant Gives Canada Domestic Production Capability for N95-Type Mask Filters

DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators

Reimagining US Public Health with Robust Application of Systems Engineering

How COVID-19 Vaccines Will Get From the Factory to Your Community

Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire

U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva

Australia Will Have Its Own Centre for Disease Control, Labor Party Vows

Biodefense Headlines – 27 April 2025